Page last updated: 2024-12-05
phenarsazine chloride
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
phenarsazine chloride: extremely irritating & poisonous; used as a war gas; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 11362 |
| SCHEMBL ID | 290774 |
| MeSH ID | M0055671 |
Synonyms (41)
| Synonym |
|---|
| fenarsazinchlorid |
| dm [chemical warfare agent] |
| qi287g628l , |
| diphenylamine chloroarsine [un1698] [poison] |
| 4-27-00-09796 (beilstein handbook reference) |
| hsdb 7599 |
| unii-qi287g628l |
| brn 0178698 |
| einecs 209-433-1 |
| nsc 86138 |
| phenarsazine, 10-chloro-5,10-dihydro- |
| fenarsazinchlorid [czech] |
| diphenylamine chloroarsine |
| epa pesticide chemical code 063901 |
| un1698 |
| phenarsazine chloride |
| caswell no. 648 |
| wln: t c666 b-as- imj bg |
| phenazarsine chloride |
| 578-94-9 |
| phenarsazine, 10-chloro- |
| chloro diphenylaminearsine |
| adamsit |
| diphenylaminechloroarsine |
| phenarsazine,10-dihydro- |
| nsc-86138 |
| nsc86138 |
| diphenylaminechlorarsine |
| phenarsazine chloride (acn) |
| adamsite |
| 10-chloro-5,10-dihydroarsacridine |
| 5-aza-10-arsenaanthracene chloride |
| 10-chloro-5,10-dihydrophenarsazine |
| SCHEMBL290774 |
| phenarsazine chloride [mi] |
| phenarsazine chloride [hsdb] |
| phenarsazinechloride |
| PBNSPNYJYOYWTA-UHFFFAOYSA-N |
| un 1698 |
| DTXSID6041890 |
| Q233052 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 18.10
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (18.10) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||